Provided by Tiger Trade Technology Pte. Ltd.

Evolent Health

5.60
+0.12002.19%
Post-market: 5.600.00000.00%19:59 EDT
Volume:1.49M
Turnover:8.23M
Market Cap:629.89M
PE:-1.19
High:5.63
Open:5.30
Low:5.29
Close:5.48
52wk High:12.03
52wk Low:2.10
Shares:112.48M
Float Shares:93.95M
Volume Ratio:0.56
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7089
EPS(LYR):-5.0732
ROE:-65.11%
ROA:-0.45%
PB:1.59
PE(LYR):-1.10

Loading ...

Evolent Health reports Q1 adjusted EPS (2c), consensus (5c)

TIPRANKS
·
May 07

Evolent Health Q1 revenue misses estimates as margin narrows

Reuters
·
May 07

Evolent Q1 FY26 net loss narrows to USD 26,632; revenue rises to USD 496.25 million

Reuters
·
May 07

Evolent Health Q1 Adj. EPS $(0.02) Beats $(0.05) Estimate, Sales $496.246M Miss $534.669M Estimate.

Benzinga
·
May 07

BRIEF-Evolent Health Q1 Revenue USD 496.246 Million Vs. IBES Estimate USD 534.7 Million

Reuters
·
May 07

Evolent Health Q1 Revenue USD 496.246 Million VS. Ibes Estimate USD 534.7 Million

THOMSON REUTERS
·
May 07

Evolent Health Inc FY2026 REV View $2.49 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
May 07

Evolent Health Q1 Adjusted Ebitda Margin 4.4%

THOMSON REUTERS
·
May 07

Evolent Health Inc expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
May 05

Evolent Health announces annual shareholder meeting

Reuters
·
Apr 25

RBC Capital Remains a Hold on Evolent Health (EVH)

TIPRANKS
·
Apr 16

Evolent Health to release first-quarter results, host conference call before market open

Reuters
·
Apr 08

Privia Health publishes 2025 annual report, revenue rises 22.3% to $2.12 billion

Reuters
·
Apr 02

Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress

GlobeNewswire
·
Mar 26

Evolent Health appoints Archie Mayani as chief product officer

Reuters
·
Mar 19

Evolent Announces Appointment of Archie Mayani as Chief Product Officer

THOMSON REUTERS
·
Mar 19

Evolent Health (EVH) Receives a Buy from J.P. Morgan

TIPRANKS
·
Mar 03

Evolent Health Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Mar 02

Evolent Health: Conservative 2026 Guidance Masks Attractive Valuation and Upside to EBITDA Targets

TIPRANKS
·
Mar 02

Evolent Health Charts Growth Amid 2026 Margin Squeeze

TIPRANKS
·
Mar 01